Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Sahel Journal of Life Sciences FUDMAOpen Access

Evaluation of Bacteriophage Therapy Against Multidrug-Resistant Pseudomonas aeruginosa Isolated from Wound Infections at Ahmadu Bello University Teaching Hospital, Zaria

View Full Paper
Ask AI
Bookmark
Share

Authors

SMShiva ManiIMIgnatius MzunguAKAdetunji M. Kilani

Discussion

Loading...

Member takes

Overview

This research evaluates bacteriophage therapy's impact on multidrug-resistant Pseudomonas aeruginosa, suggesting a potential alternative treatment method.

Key Points

  • Bacteriophages showed lytic activity against multidrug-resistant strains isolated from wound infections.
  • Eight out of fifteen clinical isolates of Pseudomonas aeruginosa were identified as multidrug-resistant.
  • Isolated bacteriophages were effective against resistant strains, indicating their therapeutic potential.
  • The findings support bacteriophage therapy as a cost-effective option in combating multidrug-resistant infections.

Cite This Study

Mani et al. (2025) studied this question.

synapsesocial.com/papers/68e02f46f0e39f13e7fa2c44https://doi.org/10.33003/sajols-2025-0303-05
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bacteriophage therapy in clinical practice: case studies of 2025 · 6 citations
  2. 2Exploration of bacteriophage therapy as a viable alternative to combat antibiotic-resistant bacterial infections: A comprehensive in vitro and in vivo evaluation2025
  3. 3Revolutionizing Infection Control: The Role of Bacteriophage Therapy in Combating Antimicrobial Resistance2025
  4. 4Unlocking the Power of Phage Therapy in Combating Antimicrobial Resistance: Insights from a Systematic Review and Meta-Analysis2025
  5. 5Augmenting phage therapy using green nanotechnology for promising infection control, wound healing and devoiding phage resistance in MDR Pseudomonas aeruginosa2025